Bioxcel therapeutics to present at thinkequity conference

New haven, conn., oct. 29, 2024 (globe newswire) -- bioxcel therapeutics, inc. (nasdaq: btai), a biopharmaceutical company utilizing artificial intelligence to develop transformative medicines in neuroscience, today announced that vimal mehta, ph.d., ceo, and vincent j. o'neill, m.d., executive vice president, chief of product development and medical officer, will present at the thinkequity conference in new york city. the presentation is set for wednesday, october 30 at 2 p.m. et.
BTAI Ratings Summary
BTAI Quant Ranking